Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$43.97 USD
+0.74 (1.71%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $43.97 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TNDM 43.97 +0.74(1.71%)
Will TNDM be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TNDM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TNDM
Here's How Thermo Fisher (TMO) is Placed Ahead of Q2 Earnings
Will WATCHMAN Sales Aid Boston Scientific's (BSX) Q2 Earnings?
TNDM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
Tandem Diabetes (TNDM) Posts Positive Data for Tandem Mobi
Other News for TNDM
Healthcare 2024 Second Half Outlook
Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
What's Driving Tandem Diabetes Care Inc's Surprising 15% Stock Rally?
Buy Rating Affirmed: Tandem Diabetes Care’s Innovative Edge and Strategic Growth Outlook
Tandem Diabetes, DexCom see weakness following ADA conference